Vilazodone: Preliminary Phase I/II data

Preliminary data from 10 patients in the dose-escalation Phase I portion of an ongoing Phase I/II trial showed 2 dose-limiting toxicities of worsening peripheral sensory neuropathy at 1.34 mg/kg IV C...